Nampt-IN-3 |
Catalog No.GC36690 |
Nampt-IN-3 (composé 35) inhibe simultanément la nicotinamide phosphoribosyltransférase (NAMPT) et l'HDAC avec des CI50 de 31 nM et 55 nM, respectivement. Nampt-IN-3 induit efficacement l'apoptose cellulaire et l'autophagie et conduit finalement À la mort cellulaire.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2121591-52-2
Sample solution is provided at 25 µL, 10mM.
Nampt-IN-3 (Compound 35) simultaneously inhibit nicotinamide phosphoribosyltransferase (NAMPT) and HDAC with IC50s of 31 nM and 55 nM, respectively. Nampt-IN-3 effectively induces cell apoptosis and autophagy and ultimately leads to cell death[1].
[1]. Dong G, et al. Small Molecule Inhibitors Simultaneously Targeting Cancer Metabolism and Epigenetics: Discovery of Novel Nicotinamide Phosphoribosyltransferase (NAMPT) and Histone Deacetylase (HDAC) Dual Inhibitors. J Med Chem. 2017 Oct 12;60(19):7965-7983.
Average Rating: 5
(Based on Reviews and 22 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *